Type 1 diabetes patients who took exenatide prior to a mixed meal tolerance test attained a 33% reduction in glucose excursion and delays in gastric emptying, according to a small study in Diabetes Care. However, the drug did not appear to boost insulin secretion rates and did not show metabolic effects when taken before an intravenous glucose tolerance test, researchers said.

Related Summaries